Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 Protocol: Starting Dose & Titration Chart (2026) thermogenic Lilly's Investigational Dual GIP Quantity:Double-Pack ($69)
Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes | Eli Lilly and Company
50% of patients achieved more than 10% weight loss compared to 0% on lifestyle changes alone 23.1% of patients achieved more than 15% weight loss compared to 0% on lifestyle changes alone
thermogenic
Quantity:Double-Pack ($69)
Additionally, patient preference for medications with dual benefits of glucose control and weight management is strengthening demand for GLP-1 therapies across global healthcare systems
US$ 27.39
US$ 26.84
US$ 28.45
US$ 20.48
US$ 27.88